Hubei Clinical Research Center

Clinical Research Center of Metabolic Cardiovascular Diseases

Name: Clinical Research Center of Metabolic Cardiovascular Diseases

Person in Charge: Huang Kai

Brief Introduction: The center was founded in 2014. Through the combination of high-quality resources from the Cardiology Department, Endocrinology Department, Gastroenterology Department, the Cardiovascular Clinical Research Center of Liyuan Hospital, the Department of Pharmacology of the School of Basic Medicine, Department of Biochemistry and Molecular Biology, and School of Public Health of Tongji Medical College, the center has been established as a domestic leading clinical medical research center of metabolic cardiovascular diseases, which contains basic and clinical practice and develop from single center to multiple centers. The center aims to comprehensively and systematically explore the change and evolution rules of the process from the occurrence of metabolic abnormalities to the occurrence and deterioration of cardiovascular diseases and even the death of patients through the integration of different disciplines and research teams and combining their respective characteristics, elucidate the pathogenesis of metabolic cardiovascular diseases, establish the standards for clinical diagnosis, prevention and treatment, and explore the effective prevention and treatment solutions suitable for the national and provincial conditions.


 

Research Directions: Aiming at cardiovascular diseases caused by metabolic abnormalities, the center systematically studies the pathogenesis of abnormal glucose and lipid metabolism and related cardiovascular diseases as well as new therapeutic targets, and seeks effective comprehensive prevention and treatment measures for metabolic cardiovascular diseases.


The establishment of the center fills the gap in the field of metabolic cardiovascular disease prevention and treatment in China. The center focuses on the clinical and basic research of metabolic cardiovascular diseases, and promotes the progress of the prevention and treatment of metabolic and cardiovascular diseases. Over the past five years, the center has obtained a total of 81 NSFC projects and 83 scientific research projects of different levels, published more than 200 research papers in SCI journals, and won three first prizes, three second prizes and three third prizes of Hubei Province Science and Technology Progress Award, and a second prize of Hubei Province Science and Technology Promotion Award.


The center has the key laboratory of biologically targeted therapy, the key laboratory of molecular imaging, the innovation platform for research and development of new drugs for cardiovascular, cerebrovascular and metabolic diseases in Hubei Province, the heart molecular biology laboratory, the electrophysiology laboratory and other research platforms, and a group of young and energetic researchers, who have made a series of remarkable research achievements.